Cargando…

Prevalence of antiplatelet therapy in patients with diabetes

OBJECTIVE: To determine the prevalence of, and patient characteristics associated with, antiplatelet therapy in a cohort of primary care patients with Type 1 or Type2 diabetes. METHODS: Subjects participating in a randomized trial of a decision support system were interviewed at home and medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Shaun R, Littenberg, Benjamin, MacLean, Charles D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1318485/ https://www.ncbi.nlm.nih.gov/pubmed/16321162 http://dx.doi.org/10.1186/1475-2840-4-18

Ejemplares similares

Intra-cluster correlation coefficients in adults with diabetes in primary care practices: the Vermont Diabetes Information System field survey
por: Littenberg, Benjamin, et al.
Publicado: (2006)

Association between the prevalence of obstructive lung disease and the use of aspirin in a diabetic population
por: Ramos-Nino, Maria E, et al.
Publicado: (2022)

Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
por: Ramos-Nino, Maria E, et al.
Publicado: (2007)

Association between prevalence of obstructive lung disease and obesity: results from The Vermont Diabetes Information System
por: Ramos-Nino, Maria E., et al.
Publicado: (2021)

Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information system
por: Ramos-Nino, Maria E, et al.
Publicado: (2008)

Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study
por: MacLean, Charles D, et al.
Publicado: (2006)

The use of adherence aids by adults with diabetes: A cross-sectional survey
por: Littenberg, Benjamin, et al.
Publicado: (2006)

Literacy and health outcomes: a cross-sectional study in 1002 adults with diabetes
por: Morris, Nancy S, et al.
Publicado: (2006)

Potential enhanced association between obstructive lung disease and history of depression in patients with diabetes
por: Ramos-Nino, Maria E, et al.
Publicado: (2021)

The use of insulin declines as patients live farther from their source of care: results of a survey of adults with type 2 diabetes
por: Littenberg, Benjamin, et al.
Publicado: (2006)

Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes
por: Gibson, Kyle R, et al.
Publicado: (2011)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

The Single Item Literacy Screener: Evaluation of a brief instrument to identify limited reading ability
por: Morris, Nancy S, et al.
Publicado: (2006)

Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease
por: Nicolajsen, Chalotte W., et al.
Publicado: (2023)

Effect of a clinical evidence technology on patient skin disease outcomes in primary care: a cluster-randomized controlled trial
por: Burke, Marianne, et al.
Publicado: (2019)

Role of magnesium supplementation in the treatment of depression: A randomized clinical trial
por: Tarleton, Emily K., et al.
Publicado: (2017)

Fitness Is Strongly Influenced by Rare Mutations of Large Effect in a Microbial Mutation Accumulation Experiment
por: Heilbron, Karl, et al.
Publicado: (2014)

Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021)

Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US
por: Wang, Yehua, et al.
Publicado: (2023)

Barriers and facilitators to use of a clinical evidence technology in the management of skin problems in primary care: insights from mixed methods
por: Burke, Marianne D., et al.
Publicado: (2020)

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial
por: Al-Shahi Salman, Rustam, et al.
Publicado: (2021)

Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
por: Gajulapalli, Rama Dilip, et al.
Publicado: (2017)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
por: Solheim, Svein, et al.
Publicado: (2013)

Association of Field Position and Career Length With Risk of Neurodegenerative Disease in Male Former Professional Soccer Players
por: Russell, Emma R., et al.
Publicado: (2021)

Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy
por: Hobson, Alex R, et al.
Publicado: (2008)

Oral Antiplatelet Therapy Administered Upstream to Patients With NSTEMI
por: Pollack, Charles V., et al.
Publicado: (2020)

Progression of Gastrointestinal Injury During Antiplatelet Therapy After Percutaneous Coronary Intervention: A Secondary Analysis of the OPT-PEACE Randomized Clinical Trial
por: He, Chen, et al.
Publicado: (2023)

Antiplatelet Therapy for Every Diabetic Person?
por: Nicolucci, Antonio, et al.
Publicado: (2011)

Prolonged dual antiplatelet therapy in patients with non‐ST‐segment elevation myocardial infarction: 2‐year findings from EPICOR Asia
por: Zou, Yanan, et al.
Publicado: (2020)

Bleeding tendency in dual antiplatelet therapy with aspirin/clopidogrel: rescue of the template bleeding time in a single-center prospective study
por: Altman, Raul, et al.
Publicado: (2012)

Dual Antiplatelet Therapy Over 6 Months Increases the Risk of Bleeding after Biodegradable Polymer-Coated Sirolimus Eluting Stents Implantation: Insights from the CREATE Study
por: ZHANG, LEI, et al.
Publicado: (2014)

Practice-Level Documentation of Alcohol-Related Problems in Primary Care
por: Waddell, Elizabeth Needham, et al.
Publicado: (2023)

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
por: Camargo, L.M., et al.
Publicado: (2014)

Prevalence, Characteristics, and Outcomes of Emergency Department Discharge Among Patients With Sepsis
por: Peltan, Ithan D., et al.
Publicado: (2022)

Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs
por: Doğan, Ali, et al.
Publicado: (2017)

Percutaneous Nephrolithotomy in Patients on Chronic Anticoagulant/Antiplatelet Therapy
por: Nerli, R B, et al.
Publicado: (2012)

Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
por: Al-Attas, Omar S, et al.
Publicado: (2009)

An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study
por: Holmes, Chris E, et al.
Publicado: (2010)

The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates
por: Al-Maskari, Fatma, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_lbb85i1g5eq42snrghfqli2rkd